1.
Murphy SA. An experimental design for the development of adaptive treatment strategies. Stat Med 2005;24:1455–1481.CrossrefGoogle Scholar
2.
Neyman J. Sur les applications de la théorie des probabilités aux experiences agricoles: Essai des principes. Roczniki Nauk Rolniczych 1923;10:1–51.Google Scholar
3.
Rubin D. Estimating causal effects of treatment in randomized and nonrandomized studies. J Educ Psychol 1974;66:688–701.CrossrefGoogle Scholar
4.
Emsley R, Dunn G, White IR. Mediation and moderation of treatment effects in randomized controlled trials of complex interventions. Stat Methods Med Res 2010;19:237–270.CrossrefGoogle Scholar
5.
Emsley R. How do treatments work and who for? Efficacy and mechanisms evaluation in complex interventions and personalized medicine. Symposium on Causal Mediation Analysis, 29 January, 2013, Gent, Belgium.Google Scholar
6.
Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877–883.CrossrefGoogle Scholar
7.
Kraemer HC, Kiernan M, Essex M, Kupfer DJ. How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol 2008;27(2):S101-S108.Web of ScienceGoogle Scholar
8.
Zhang R, Faerber J, Joffe M, Ten Have T Post-randomization interaction analyses in clinical trials with standard regression. Manuscript submitted for publication.Google Scholar
9.
Almirall D, Ten Have T, Murphy SA. Structural nested mean models for assessing time-varying effect moderation. Biometrics 2010;66:131–139.CrossrefWeb of ScienceGoogle Scholar
10.
Normand SL. Evaluating the optimal timing of angiography: landmark or off the mark? Circulation 2007;116:2656–2657.Web of ScienceCrossrefGoogle Scholar
11.
Joffe MM, Hoover DR, Jacobson LP, Kingsley L, Chmiel JS, Fischer BR, et al. Estimating the effect of Ziduvodine on Kaposi’s sarcoma from observational data using a rank preserving failure time model. Stat Med 1998;17:1073–1102.CrossrefGoogle Scholar
12.
Ten Have TR, Joffe MM, Lynch K, Maisto S, Brown G, Beck T. Causal mediation analyses with rank preserving models. Biometrics 2007;63:926–934.Web of ScienceCrossrefGoogle Scholar
13.
Ilardi SS, Craighead WE. The role of nonspecific factors in cognitive behavioral therapy for depression. Clin Psychol Sci Pract 1994;1:138–156.CrossrefGoogle Scholar
14.
Tang TZ, DeRubeis RJ. Reconsidering rapid early response in cognitive behavioral therapy for depression. Clin Psychol Sci Pract 1999;6:283–288.CrossrefGoogle Scholar
15.
Haas E, Hill R, Lambert M, Morrell B. Do early responders to psychotherapy maintain treatment gains?. J Clin Psychol 2002;58:1157–1172.CrossrefGoogle Scholar
16.
Lambert MJ. Early response in psychotherapy: further evidence for the importance of common factors rather than placebo effects. J Clin Psychol 2005;61:855–869.CrossrefGoogle Scholar
17.
Young MA, Fogg LF, Scheftner W, Fawcett J, Akiskal H, Maser J. Stable trait components of hopelessness: baseline and sensitivity to depression. J Abnorm Psychol 1996;105:155–165.CrossrefGoogle Scholar
18.
Kuyken W. Cognitive therapy outcome: the effect of hopelessness in a naturalistic outcome study. Behav Res Ther 2004;42:631–646.CrossrefGoogle Scholar
19.
Feldman G. Cognitive and behavioral therapies for depression: overview new directions and practical recommendations for dissemination. Psychiatr Clin N Am 2007;30:39–50.CrossrefGoogle Scholar
20.
Murphy S, Lynch KG, Oslin D, McKay JR, TenHave T. Developing adaptive treatment strategies in substance abuse research. Drug Alcohol Depend 2007;88(Suppl 2):S24–S30.Google Scholar
21.
Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT. Cognitive therapy for the prevention of suicide attempts: A randomized controlled trial. J Am Med Assoc 2005;294:2847–2848.Google Scholar
22.
Beck AT, Steer RA, Brown GK. Manual for Beck depression inventory-II. Texas: Psychological Corporation, 1996.Google Scholar
23.
Beck AT, Brown GK, Steer RA. Psychometric characteristics of the scale for suicide ideation with psychiatric outpatients. Behav Res Ther 1997;35:1039–1046.CrossrefGoogle Scholar
24.
D’Zurilla TJ, Nezu AM, Maydeu-Olivares A. Social Problem-Solving Inventory-Revised (SPSI-R): technical manual. New York: Multi-Health Systems, 2002.Google Scholar
25.
Small DS, Joffe MM, Lynch KG, Roy JA, Localio AR. Tom Ten Have’s contributions to causal inference and biostatistics: review and future research directions. Stat Med 33:3421–3433. (correction on page 3600).Web of ScienceCrossrefGoogle Scholar
26.
Rubin D. Statistics and causal inference: comment: which ifs have causal answers. J Am Stat Assoc 1986;81:961–962.Google Scholar
27.
Wooldridge JM. Econometric analysis of cross section and panel data, 2nd ed. The MIT Press, 2010. Chapter 5.Google Scholar
28.
Robins JM. Correcting for non-compliance in randomized trials using structural nested mean models. Communications Stat 1994;23:2379–2412.CrossrefGoogle Scholar
29.
Robins JM, Rotnitzky A, Scharfstein D. Sensitivity analysis for selection bias and unmeasured confounding in missing data and causal inference models. In: Halloran ME, Berry D, editors. Statistical models in epidemiology: the environment and clinical trials, vol. IMA ume 116. NY: Springer-Verlag, 1999:1–92.Google Scholar
30.
Rosenbaum PR. The consequence of adjustment for a concomitant variable that has been affected by the treatment. J Royal Statistical Society Ser Gen 1984;147:656–666.CrossrefGoogle Scholar
31.
Robins JM. A new approach to causal inference in mortality studies with sustained exposure periods- application to control of the healthy worker survivor effect. Math Model 1986;7:1393–1512.CrossrefGoogle Scholar
32.
Cole SR, Frangakis CE. The consistency statement in causal inference: A definition or an assumption?. Epidemiology 2009;20(1):3–5.CrossrefWeb of ScienceGoogle Scholar
33.
VanderWeele TJ. Concerning the consistency assumption in causal inference. Epidemiology 2009;20(6):880–883.Web of ScienceCrossrefGoogle Scholar
34.
Robins J, Rotnitzky A. Estimation of treatment effects in randomized trials with non compliance and a dichotomous outcome using structural mean models. Biometrika 2004;91:763–783.CrossrefGoogle Scholar
Comments (0)